Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 16932965 | HLA-B*51 | pleocytosis | NA | NA | NA | positive | |
| both patients showed a mild csf pleocytosis, and were positive for hla-b51. | |||||||
| 23037550 | HLA-DRB1*13 | pleocytosis | NA | NA | NA | unclassified | |
| laboratory analysis showed cerebrospinal fluid pleocytosis (45%), nmo-igg (9%), antinuclear antibodies (70%), and genotype hla-drb1*13 (57%). | |||||||
| 23037550 | HLA-DRB1 (HLA-DRB1) | neuromyelitis optica | NA | NA | NA | unclassified | |
| hla-drb1 genotype was compared with those of 225 normal controls and patients with ms (228) and neuromyelitis optica (nmo) (22). | |||||||
| 33934701 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | pleocytosis | NA | fluorescein | NA | unclassified | |
| cerebrospinal fluid examination showed pleocytosis and human leukocyte antigen testing showed expression of the dr04 phenotype; therefore, the patient was diagnosed with so. | |||||||
| 33520030 | HLA (HLA) | fungal infection | NA | everolimus | NA | unclassified | |
| the present case had three problems that were linked to each other: (1) anti-hla antibodies, (2) fungal infection, and (3) pre-transplantation renal dysfunction. | |||||||
| 8648389 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic malignancies | NA | prednisone | NA | unclassified | |
| all patients had hematopoietic malignancies and received transplants from hla-identical sibling donors. | |||||||
| 17530010 | HLA-A*02 | hematopoietic malignancies | Caucasian | NA | NA | unclassified | |
| ha-1(h) is one of the most attractive minor histocompatibility antigens (mha) as a target for immunotherapy of hematopoietic malignancies, but hla-a*0201 and hla-b60 molecules capable of presenting ha-1(h)-derived peptides are less common in eastern asian populations when compared with caucasian populations. | |||||||
| 17530010 | HLA-B60 (BROAD ANTIGEN) | hematopoietic malignancies | Caucasian | NA | NA | unclassified | |
| ha-1(h) is one of the most attractive minor histocompatibility antigens (mha) as a target for immunotherapy of hematopoietic malignancies, but hla-a*0201 and hla-b60 molecules capable of presenting ha-1(h)-derived peptides are less common in eastern asian populations when compared with caucasian populations. | |||||||
| 17530010 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | Caucasian | NA | NA | unclassified | |
| therefore, an attempt was made to search for novel epitopes presented by hla alleles other than those previously reported by generating ctl lines from patients undergoing hla-identical, ha-1 disparate hematopoietic stem cell transplantation (hematopoietic sct) by stimulation with a 29-mer ha-1(h) peptide spanning a central polymorphic histidine (his). | |||||||
| 30232415 | HLA (HLA) | hematopoietic malignancies | NA | NA | NA | unclassified | |
| umbilical cord blood (ucb) represents a valid option for patients with hematopoietic malignancies lacking an hla matched donor. | |||||||
Copyright 2024